English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduSusan M. Domchek, MD, FASCO, has been recognized by the American Society of Clinical Oncology (ASCO) with one of the society’s highest honors, as the 2025 recipient of the ASCO-American Cancer Society Cancer Prevention Award.
Tag: Vaccine
CDC Reports a Rise in Flu Cases
The US is experiencing a wave of respiratory illness this winter, with a surge in flu cases and an uptick in hospitalizations. A new CDC report shows the rising influenza threat in states, according to news reports.
What’s Next for Weight Loss in 2025? Some Say It’s Time to Say Goodbye to the BMI, Among Other Things…
This National Healthy Weight Week, there’s a growing call to overhaul the way obesity is currently diagnosed.
Fewer Kids are Getting Flu Shots, According to CDC
Just over a third of U.S. kids have received the flu shot as of November 30th, according to the CDC. That number is down from this time last year. According to the CDC, there has been a slight increase in…
The Medical Minute: Shingles and its shot: What you need to know to stay healthy
The same virus that causes chickenpox can also reemerge as shingles, causing a painful string of rashes. A Penn State Health family medicine physician discusses the symptoms and why he recommends the shingles vaccine for adults 50 and older and adults with weakened immune systems.
WHO Authorizes First Monkeypox Vaccine for Children
The first mpox vaccine for children has been approved by The World Health Organization. The vaccine is approved for children over the age of one. This comes as Congo and other parts of Africa are being hit the hardest with…
Number of Whooping Cough Cases on Rise Nationally
Whooping cough is making a comeback, and medical providers say the highly contagious bacterial infection that causes severe coughing fits is preventable.
During the COVID-19 pandemic, whooping cough, also known as pertussis, declined dramatically.
Según un nuevo estudio, el rechazo a las vacunas es menor entre las minorías
Durante la pandemia de COVID, los medios informaron ampliamente que los pacientes negros tenían más probabilidades que los pacientes blancos de rechazar las vacunas, incluidas las vacunas contra la influenza y el COVID. Un nuevo estudio que se presentará en la Reunión Científica Anual del Colegio Americano de Alergia, Asma e Inmunología (ACAAI) de este año en Boston mostró que los pacientes que se identifican como no blancos tenían menos probabilidades de mostrar desconfianza en cuando a las vacunas que los pacientes que se identifican como blancos.
Vaccine Refusal Lower in Minorities in New Study
Throughout the Covid pandemic, media widely reported that Black patients were more likely than White patients to refuse vaccines, including the influenza and Covid vaccines. A new study being presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Boston showed that self-identified non-White patients were less likely to demonstrate vaccine-hesitancy than the self-identified White patient group.
Respiratory Virus Season Is Here, But There Are Effective Ways To Protect Yourself And Your Family
Pitch for effective protection for respiratory viruses
Yale School of Medicine Professors Elected to National Academy of Medicine
Yale School of Medicine professors Erol Fikrig, MD, and Haifan Lin, PhD, have been elected to the National Academy of Medicine.
Penn Medicine and Children’s Hospital of Philadelphia Create mRNA Vaccine to Prevent and Treat C. difficile
A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides difficile infection, more commonly known as C. difficile or C. diff. In animal models, this first mRNA-LNP C. difficile vaccine was found to protect against C. difficile first-time infections and relapsing infections by inducing a robust immune response, promote clearance of existing C. diff bacteria from the gut, and even overcome deficits in host immunity to protect animals after infection.
An AI-powered pipeline for personalized cancer vaccines
Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses artificial intelligence algorithms to use its output to design personalized cancer vaccines for patients.
Scientists at The Wistar Institute Discover Novel Series of SARS-CoV-2 Mpro Inhibitors for Potential New COVID-19 Treatments
New research from the Salvino lab identifies novel series of MPro inhibitors
Houston Methodist part of national consortium to develop vaccine against herpesviruses
Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government’s Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects.
Most pregnant people got vaccinated for COVID-19 in 2022
A study of more than 28,000 pregnancies from 2022 has found that the majority of pregnant people received the COVID-19 vaccine during its initial release.
FDA Approves At Home Flu Vaccine
The US Food and Drug Administration has approved a flu vaccine to be taken at home. FluMist is a nasal spray by AstraZencea which has been on the market since 2003 to protect against the respiratory virus. However, the FDA…
COVID-19 hits older adults hardest; which ones want the updated vaccine
A poll of people over the age of 50 shows that just under half are likely to get the updated COVID-19 vaccine, though those in the highest-risk age groups are more likely.
Risk of long COVID declined over course of pandemic
The risk of long COVID has declined over the course of the pandemic, although it remains a persistent threat. Researchers from Washington University School of Medicine in St. Louis identified vaccination as a primary factor in reducing the risk of long COVID.
The effect of covid policy restrictions on donations during the sustainable and entrepreneurial context
Abstract Using real platform data, this paper assesses donors’ reactions to a rare event; specifically, we demonstrate how donors were able to compensate for (or stabilize) healthcare deficits and policy restrictions used to mitigate the spread of COVID-19. Based on…
COVID/Flu Experimental Vaccine Receives Positive Results in Trial
A vaccine that could offer protection against COVID-19 and the flu has received positive results during trials.According to the drug maker, Moderna the shot called mRNA-1083 showed encouraging results among older adults. The trial for the dual-purpose vaccine involved more…
FDA Recommends Updated COVID-19 Vaccine for Fall
The Food and Drug Administration advisory panel is recommending a Covid-19 vaccine for the fall should be updated. The updated version would target the JN.1 variant which is currently the most dominant strain. According to the CDC, it counts for…
FDA Green-Lights Moderna Vaccine for Older Adults
The US Food and Drug Administration has approved Moderna’s mRNA vaccine for older adults to protect against respiratory syncytial virus (RSV). The vaccine, called mRESVIA, is for people ages 60 and older. According to a company press release, this marks…
Nanoparticle Vaccines: A Leap Forward in Veterinary Medicine
A recent review explores the innovative use of self-assembled protein nanoparticles (SAPNs) and virus-like particles (VLPs) in veterinary vaccine development. The research highlights the superior safety and efficacy of these nanovaccines over traditional formulations, offering a promising future for animal health and disease prevention.
Not sure about vaccines? How public health messaging is framed makes a difference, new research reveals
What’s the best way to communicate with a vaccine-hesitant person about a vaccine’s potential benefits? New research from Binghamton University, State University of New York found that a one-size-fits-all approach to communicating messages isn’t effective.
Future Parents More Likely to Get RSV Vaccine When Pregnant if Aware That RSV Can Be a Serious Illness in Infants
A nationwide survey of people who were pregnant or trying to become pregnant found that overall 54 percent expressed interest in the RSV vaccine during pregnancy. Perceiving RSV as a serious illness in infants was the strongest predictor of likely vaccination during pregnancy. Likelihood to receive the RSV vaccine during pregnancy was also higher among parents with a child at home already. Findings were published in the journal Pediatrics.
Developing Research into Mpox Infections
The Martinot Lab at Cummings School of Veterinary Medicine at Tufts University, where faculty and students have been researching the mpox virus in endometrial tissues to raise awareness of the potential increased risk of mpox virus for women.
Akiko Iwasaki, PhD, receives 2024 Tsukahara Memorial Award
Yale School of Medicine immunobiologist Akiko Iwasaki, PhD, will receive the 2024 Nakaakira Tsukahara Memorial Award from the Brain Science Foundation of Japan.
Covid Vaccines Not Linked to Fatal Heart Problems in Young People, CDC Finds
William Borden, is a professor of medicine and health policy at the GW School of Medicine and Health Sciences. He specializes in preventive cardiology, the treatment of complex cholesterol disorders, and diagnosing and treating general cardiovascular diseases. Brian Choi, is…
CDC Urges Vaccination Amid Rise in Measles Cases in the US and Globally
Jose Lucar is an associate professor of infectious diseases at the GW School of Medicine and Health Sciences. Maria Elena Ruiz is an associate professor of medicine and an infectious disease expert at the GW School of Medicine and Health…
Mutations do not predict the severity of current variants of SARS-CoV-2
New research from UNC Charlotte’s Center for Computational Intelligence to Predict Health and Environmental Risks has found that the two most prevalent strains of the virus that cause COVID-19, SARS-CoV-2 variants BA.2.86 and JN.1, are not significantly better than their predecessor Omicron at evading immune responses and causing infections despite having a high number of mutations compared to previous variants.
Calder Biosciences Inc. Publishes Next-Generation Vaccine Technology in Nature Communications
Calder Biosciences, Inc., a next-generation vaccine company, has been published in a Nature Communications article that debuts and validates the application of Calder’s ‘3D Vaxlock’ platform technology.
Breastfeeding after COVID-19 booster can give babies antibodies
A recently published study that shows lactating mothers who get the COVID-19 booster pass along the antibodies to their children via their breast milk – and potentially protect babies too young to receive the vaccine.
MSU co-authored study: 10 insights to reduce vaccine hesitancy on social media
Young Anna Argyris, associate professor in the Michigan State University Department of Media and Information, is part of an international team studying the detrimental effects of vaccine misinformation on social media and interventions that can increase vaccine uptake behaviors.
Study Could Help Clear Up Confusion and Hesitancy Surrounding RSV Vaccines
Efforts to vaccinate vulnerable populations against respiratory syncytial virus (RSV) faced an uphill battle this season. However, now a new study by researchers at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) could help to combat RSV vaccine misinformation and quell vaccine…
Pharmacology Expert Comments on RSV Vaccination Errors
The Centers for Disease Control and Prevention (CDC) reports that some pregnant Americans may have been given the wrong RSV vaccine, and some young children received a vaccine approved for use in adults only. Now, a pharmacology expert at New York Institute…
Johns Hopkins Study Supports Potential for Injectable ‘Chemical Vaccine’ For Malaria Using Atovaquone
Johns Hopkins researchers looking to develop a long-acting, injectable malaria preventive using atovaquone have shown in a new study that resistance may not be the challenge scientists thought it was, particularly when using atovaquone as a malaria preventive.
GW Experts Available: CDC Report Finds Older Adults Make Up Two-Thirds of Covid-19 Hospitalizations
WASHINGTON (October 11, 2023) – According to a recent report by the U.S. Centers for Disease Control and Prevention, adults 65 and older accounted for nearly two-thirds of Covid-19 hospitalizations in the United States this year, 61% of intensive care unit admissions and…
Vaccine via the nasal passage could be the new line of defence against Strep A
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
Johns Hopkins Bloomberg School of Public Health Media Briefing on Preventing the Spread of Flu, COVID, and RSV This Fall
The Johns Hopkins Bloomberg School of Public Health is hosting an expert briefing for the media from 2:00 p.m. to 2:30 p.m. EDT, Thursday, October 12, on how to take steps to stay healthy as COVID and RSV cases climb and flu season approaches.
Vaccine alone won’t eliminate malaria, but key addition to toolkit
Megan Greischar, assistant professor of ecology and evolutionary biology at Cornell University, studies parasites and the transmission of infection – particularly, malaria. Her recent research looked at malaria diagnostics and the impact on vaccine efficacy. Greischar says: “Eliminating vector-borne diseases…
Leave No One Behind: The Forum of International Respiratory Societies Calls for Equitable Access to Prevention and Treatment on World Lung Day 2023
This World Lung Day, Sept. 25, the Forum of International Respiratory Societies (FIRS) and its founding member the American Thoracic Society, is calling on governments and health care providers worldwide to give equitable access to preventative services and treatments for respiratory conditions, and lifesaving pneumonia vaccines for children.
Five New Health Systems Partner with American Thoracic Society on Vaccine Initiative
As cities brace for a confluence of flu, COVID-19, pneumonia, and RSV infections this fall, the American Thoracic Society announced that five new health systems have partnered with the Society to improve vaccination rates.
Global background rates study analyzes data from 197 million people for assessment of COVID-19 vaccine safety
The US CDC (Centers for Disease Control and Prevention) funded Global COVID Vaccine Safety Project has generated background incidence rates on a range of conditions designated as AESI (Adverse Events of Special Interest) for COVID-19 vaccine safety monitoring. Conditions studied included myocarditis, pulmonary embolism, and Guillain-Barré syndrome.
Getting vaccines for flu, RSV, pneumonia and COVID.
David Winter, MD, at Baylor Scott & White Health, answers the most common patient questions and reacts to the latest medical research. With flu season approaching, who should get a flu shot and when? (SOT@ :14, TRT :24) RSV cases…
The Future of Medicine Rises in University City: University of Pennsylvania Opens New Multi-Disciplinary Research Labs in One uCity Square
Wexford Science & Technology, LLC and the University of Pennsylvania today announced that the University has signed a lease for new laboratory space that will usher in a wave of novel vaccine, therapeutics and engineered diagnostics research to West Philadelphia.
Public health expert offers advice re: new COVID-19 variants and fall vaccines
A late summer increase in COVID-19-related hospitalizations and the emergence of new coronavirus variants raises concerns about how best to counter infection and who should receive the newly-approved vaccines.
Mapping the coronavirus spike protein could provide insight into vaccine development
Although the COVID-19 pandemic was the first time most of humanity learned of the now infamous disease, the family of coronaviruses was first identified in the mid-1960s.
Dr. Carol Nwelue discusses how to keep your kids healthy when going back to school.
Carol Nwelue, MD, at Baylor Scott & White Health, answers common patient questions and reacts to the latest medical research. How can parents keep their kids healthy this back-to-school season? (SOT@ 0:14, TRT 0:34) Why do sicknesses spread easily when…
COVID-19 Vaccines: What Parents Need to Know Now
The coronavirus pandemic is no longer a national emergency, but the virus that causes COVID-19 isn’t gone—and neither is the risk of getting the disease. For parents, navigating when to get their child vaccinated and knowing how to best protect their child from COVID-19 can be complicated. We spoke to Michael Smit, MD, MSPH, Hospital Epidemiologist and Medical Director of Infection Prevention and Control at Children’s Hospital Los Angeles, to get an update on the latest COVID-19 vaccine information and precautions.